November 18, 2020
The investigation of psychedelic drugs for their medical benefits is attracting investors. How does the leading US drug agency feel?
September 23, 2020
Psychedelic therapies including psilocybin are increasingly being considered for their remedial and medical benefits by health organizations across North America.
August 13, 2020
INN chatted with Adele Byrne, senior analyst at Prohibition Partners, about the early start for the psychedelics market.